Back to A1 a16z Capital Management, L.L.C.

MAZEMAZE

7 quarters

Position history for A1a16z Capital Management, L.L.C.'s holdings in Maze Therapeutics, Inc.

Yes. a16z Capital Management holds 1,702,225 shares of MAZE (Maze Therapeutics), worth $46.3M, as of its Q3 2026 13F filing. The share count is unchanged from Q2 2026. a16z Capital Management has listed MAZE in each of its last 7 quarterly 13F filings. MAZE is 0.2% of a16z Capital Management's reported 13F portfolio.

Current Value

$46.3M

Current Shares

1.7M

Total Value Change

+$27.5M

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Unchanged
1.7M
0.0%
$46.3M0.2%$27.18
0
2026-Q2
Unchanged
1.7M
0.0%
$50.8M0.4%$29.84
0
2026-Q1
Unchanged
1.7M
0.0%
$50.8M3.9%$29.85
0
2025-Q4
Unchanged
1.7M
0.0%
$70.5M4.5%$41.43
0
2025-Q3
Unchanged
1.7M
0.0%
$44.1M3.2%$25.93
0
2025-Q2
Unchanged
1.7M
0.0%
$20.9M6.7%$12.27
0
2025-Q1
New
1.7M
—
$18.7M2.7%$11.01
76

Optional analytics helps us improve. How it’s used